Could a pill replace standard hormone shots for prostate cancer?

NCT ID NCT07299292

Recruiting now Disease control Sponsor: SMED Clinical Research Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated May 24, 2026 · Updated 23 times

Summary

This study tests whether a daily pill (abiraterone with prednisone) can lower testosterone enough to control prostate cancer, avoiding the usual hormone-blocking injections. About 60 men with high-risk or advanced prostate cancer will take the pill for 30 days to see if it works. If successful, this could offer a more convenient treatment option.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER (DIAGNOSIS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Hospital Carlos A Durand
RECRUITING

Buenos Aires, 5044, Argentina

Contact Phone: •••-•••-•••• Email: •••••@•••••
Hospital San José
NOT_YET_RECRUITING

Hermosillo, Spain

Contact Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••
Instituto Oriente Boliviano
RECRUITING

Santa Cruz de la Sierra, 10260, Spain

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

PROSTATE CANCER (DIAGNOSIS)